Stocks With The Most
Fund Call Options
| Name | Net Calls | Calls | Puts |
Return since 30 Jun ‘22 |
|
|---|---|---|---|---|---|
| $14M | $285M | $271M | 39.8% |
|
|
| $14M | $94.8M | $80.7M | 154% |
|
|
| $14M | $26.4M | $12.4M | 60% |
|
|
604
Iovance Biotherapeutics
IOVA
$767M
| $14M | $32.1M | $18.1M | 80.8% |
|
| $13.9M | $28.2M | $14.3M | 125% |
|
|
| $13.9M | $22.1M | $8.2M | 53.8% |
|
|
| $13.9M | $15.5M | $1.62M | 62.7% |
|
|
| $13.9M | $16.7M | $2.8M | 7.47% |
|
|
| $13.8M | $312M | $299M | 115% |
|
|
| $13.8M | $16M | $2.15M | 75% |
|
|
611
Protagonist Therapeutics
PTGX
$4.79B
| $13.8M | $18.8M | $4.96M | 873% |
|
| $13.8M | $24.9M | $11.1M | 36.4% |
|
|
| $13.8M | $27.3M | $13.5M | 89.8% |
|
|
| $13.8M | $20.7M | $6.95M | 10.8% |
|
|
| $13.8M | $57.9M | $44.2M | 46.2% |
|
|
| $13.7M | $117M | $104M | 46% |
|
|
| $13.7M | $17.5M | $3.81M | 98.5% |
|
|
| $13.7M | $43.1M | $29.4M | 51% |
|
|
| $13.7M | $22.6M | $8.88M | 92.8% |
|
|
| $13.6M | $82.3M | $68.7M | 23.4% |
|
|
| $13.5M | $27.2M | $13.8M | 23.3% |
|
|
| $13.5M | $151M | $137M | 106% |
|
|
| $13.4M | $15.4M | $2.06M | 62.4% |
|
|
| $13.4M | $26.2M | $12.8M | 10.3% |
|
|
| $13.3M | $1.66B | $1.65B | 23.6% |
|